Abstract:Gene mutations linked to diseases like cancer may be caused by exposure to environmental chemicals. The X-linked phosphatidylinositol glycan class A (PIG-A) gene, required for glycosylphosphatidylinositol (GPI) anchor biosynthesis, is a key target locus for in vitro genetic toxicity assays. Various organisms and cell lines may respond differently to genotoxic agents. Here, we compared the mutagenic potential of directly genotoxic ethyl methane sulfonate (EMS) to metabolically activated pro-mutagenic polycyclic aromatic hydrocarbons (PAHs). The two classes of mutagens were compared in an in vitro PIG-A gene mutation test using the metabolically active murine hepatoma Hepa1c1c7 cell line and the human TK6 cell line, which has limited metabolic capability. Determination of cell viability is required for quantifying mutagenicity. Two common cell viability tests, the MTT assay and propidium iodide (PI) staining measured by flow cytometry, were evaluated. The MTT assay overestimated cell viability in adherent cells at high benzo[a]pyrene (B[a]P) exposure concentrations, so PI-based cytotoxicity was used in calculations. The spontaneous mutation rates for TK6 and Hepa1c1c7 cells were 1.87 and 1.57 per million cells per cell cycle, respectively. TK6 cells exposed to 600 µM and 800 µM EMS showed significantly higher mutation frequencies (36 and 47 per million cells per cell cycle, respectively). Exposure to the pro-mutagen benzo[a]pyrene (B[a]P, 10 µM) did not increase mutation frequency in TK6 cells. In Hepa1c1c7 cells, mutation frequencies varied across exposure groups (50, 50, 29, and 81 per million cells per cell cycle when exposed to 10 µM B[a]P, 5-methylcholanthrene (5-MC), chrysene, or 16,000 µM EMS, respectively). We demonstrate that the choice of cytotoxicity assay and cell line can determine the outcome of the Pig-A mutagenesis assay when assessing a specific mutagen.

Study on Mutagenicity of C6 Cells HGPRT-Lines

Establishment of Hypoxanthine Guanine Phosphoribosyi Transferase Mutant from Human Liver Cancer Cell Line HepG2

Modulation of G6PD Affects Bladder Cancer Via ROS Accumulation and the AKT Pathway in Vitro.

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

Study on relationship between mutant p53 and multidrug resistance gene 1 in gastric cancer

Killing effect of mutant herpes simplex virus type 1 thymidine kinase on rat C6 glioma cells

Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals?

Establishment and Identification of HGPRT Deficient T Cell Line

[Effect of Wt P53 Gene Transfection on Sensitivity of Hyperthermia in C6 Glioma Cells].

The anti-proliferative effects of rHSG gene on glioblastoma cells through P53-P21cip1 pathway

[Activation of Proto-Oncogenes Induced by MNNG on Primary Culture of Human Gastric Epithelium and Immortalized Human Gastric Epithelial Cell Line].

Establishment and Identification of HGPRT Deficient Hela Cell Line

Comparisons of Induced Mutations at TK and HPRT Loci Using Two Human Lymphoblastoid Cell Lines

Isolation of Alkylating Agent-Sensitive Chinese Hamster Ovary Cell Lines

6-Thioguanine and <i>S</i><sup>6</sup>-methylthioguanine are Mutagenic in human Cells

Assessment of the In Vitro Phosphatidylinositol Glycan Class A (PIG-A) Gene Mutation Assay Using Human TK6 and Mouse Hepa1c1c7 Cell Lines

Detection of Antimutagenicity of Ginsenoside Re by TK Gene and HGPRT Gene Mutation Test

Analysis of Spontaneous, Gamma Ray- and Ethylnitrosourea-Induced Hprt Mutants in Hl-60 Cells with Multiplex Pcr

Studies on the Radiation Induced Bystander Effects on hprt and CD59 Genes of Human-hamster Hybrid A_L Cells

Effect of Transfection with p53 Gene on Malignancy of Human Hepotacellular Carcinoma Cell Lines

GENOTOXIC EFFECTS OF CYTOPLASMIC IRRADIATION